13
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22675 |
Co 102862
V 102862 |
Others; Sodium Channel | Membrane transporter/Ion channel; Others |
Co 102862 是一种电压门控钠通道阻滞剂。 Co 102862 可用于抗惊厥的研究。 | |||
T8711 |
PF-05186462
PF-05150122 |
Sodium Channel | Membrane transporter/Ion channel |
PF-05186462 (PF-05150122)是选择性的人Nav1.7电压依赖性钠通道抑制剂,IC50为 21 nM,与其他钠通道 (Nav 1.1、1.2、1.3、1.4、1.5、1.6 和 1.8) 相比,它对 Nav1.7显示出显著的选择性。PF-05186462在急性或慢性疼痛中具有研究价值。 | |||
T33816 |
Ordopidine
ACR-325,ACR 325,ACR325 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Ordopidine (ACR325) 是一种多巴胺能稳定剂,可抑制精神刺激剂引起的多动症,并在不活动时刺激行为。Ordopidine 在体外作为多巴胺 D2 受体拮抗剂起作用,尽管亲和力低,但其依赖于特定状态的行为效应特征是 D2 受体拮抗剂所不具备的。 | |||
T14884 |
CBR-5884
|
Others; Dehydrogenase | Metabolism; Others |
CBR-5884 是一种磷酸甘油酸脱氢酶抑制剂,IC50为 33 μM。 它抑制癌细胞中的丝氨酸合成,选择性地抑制黑素瘤和乳腺癌细胞系的增殖,对具有高丝氨酸生物合成活性的癌细胞系有选择性毒性。 | |||
T24902 |
TROX-1
TROX1,TROX 1 |
Others | Others |
TROX-1 is the activation state-dependent Cav2 channel antagonist. | |||
T14992 |
Raxatrigine hydrochloride
GSK-1014802 hydrochloride,CNV1014802 (hydrochloride) |
Others | Others |
Raxatrigine hydrochloride is a state-dependent sodium channel blocker and a Nav1.7 sodium channel inhibitor. | |||
T7352L |
Pridopidine hydrochloride
ASP2314 HCl,Pridopidine HCl,FR310826,ASP-2314 hydrochloride |
Others | Others |
Pridopidine Hydrochloride is a dopaminergic stabilizer that has been shown to improve a variety of neurological and psychiatric disorders, including Huntington's disease. Pridopidine Hydrochloride stabilizes psychomotor activity in a state-dependent way t | |||
T71239 |
CNV-2197944
|
Others | Others |
CNV-2197944 is a novel, small molecule, state-dependent calcium channel blocker, designed to selectively inhibit highly active Cav2.2 channels. | |||
T23652 |
AFD-21
AFD21,NS-2 Class 1 antiarrhythmic agent |
Others | Others |
AFD-21是一种 I 类抗心律失常药物。它在钠通道失活状态下与钠通道结合,对钠通道具有使用和电压依赖性抑制作用,其解结合率与具有中等动力学的I 类抗心律失常药物相当。 | |||
T79280 |
Nav1.3 channel inhibitor 1
|
Sodium Channel | Membrane transporter/Ion channel |
Nav1.3 channel inhibitor 1 (化合物 15b) 为状态依赖性电压门控钠通道Nav1.3的抑制剂,具有IC50值为20 nM。该化合物能穿透血脑屏障,适用于神经系统疾病研究。 | |||
T70004 |
APS-2-79
|
Others | Others |
APS-2-79 是一种 KSR 依赖性的MEK 拮抗剂。APS-2-79 与 ATPbiotin 竞争性地结合到 KSR2-MEK1 复合物内的KSR2,IC50为 120 nM。APS-2-79 与 KSR 结合可将 KSR 固定在一个非活性的状态,使其无法再结合RAF 和激活MEK,从而阻断了 Ras-MAPK 信号通路。 | |||
T35946 |
17(R)-Resolvin D1
Aspirin-triggered Resolvin D1,17(R)-Resolvin D1 |
Others | Others |
Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.[1] In addition to being anti-inflammatory, resolvins promote the resolution of the inflammatory response back to a non-inflamed state.[2] Resolvin D1 is produced physiologically from the sequential oxygenation of DHA by 15- and 5-lipoxygenase.[1] 17(R)-RvD1 is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte (PMN) transendothelial migration, the ear... | |||
T36717 |
RWJ-56110 dihydrochloride
|
Others | Others |
RWJ-56110 dihydrochloride is a potent, selective, peptide-mimetic inhibitor of PAR-1 activation and internalization (binding IC50=0.44 uM) and shows no effect on PAR-2, PAR-3, or PAR-4. RWJ-56110 dihydrochloride inhibits the aggregation of human platelets induced by both SFLLRN-NH2 (IC50=0.16 μM) and thrombin (IC50=0.34 μM), quite selective relative to U46619 . RWJ-56110 dihydrochloride blocks angiogenesis and blocks the formation of new vessels in vivo. RWJ-56110 dihydrochloride induces cell ap... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2830 |
26-Nor-8-oxo-alpha-onocerin
|
Others | Others |
26-Nor-8-oxo-alpha-onocerin can promote the osteoblast proliferation rate, the effect is time-dependent,concentration-dependent and differentiation state-dependent. | |||
TN3844 |
Didrovaltrate
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Didrovaltrate shows cytotoxic against human cancer cell lines. Didrovaltrate blocks I(Ca-L) in a concentration-dependent manner and probably inhibits I(Ca-L) in its inactive state, which may contribute to its cardiovascular effect. |